18 Another study found a significant reduction in pain, with 82% having complete resolution of pain, after 2 months of taking 30mg of resveratrol with OCPs
Compared with conventional antioxidants, nanomaterials, including nanozymes, metal-based nanoparticles, biomacromolecular nanomaterials, and ROS-responsive nanocarriers, exhibit superior stability, targeted delivery capability, and sustained therapeutic efficacy
In an analysis of the US Diabetes Collaborative Registry [17], Arnold and colleagues studied 182,525 patients with diabetes in the US Diabetes Collaborative Registry that included 313 cardiology, endocrinology, and primary care practices and noted that 48% of such patients fit LEADER eligibility criteria
FDA just approved Foundayo (orforglipron) Lilly's once-daily oral GLP-1 for obesity